Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel or generic controlled-release and targeted-release oral solid dosage drugs. The Companyâ€™s patented Hypermatrixâ„¢ technology is a unique and validated multidimensio
... morenal controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals. Based on this technology, Intellipharmaceutics has a pipeline of products in various stages of development, including five ANDAs filed with the FDA, in therapeutic areas that include neurology, cardiovascular, GIT, pain and infection.less
Safe Harbor Statement
Certain statements on this web site constitute â€œforward-looking statementsâ€ within the meanin...
Director of Investor Relations